Is it possible to use anthracyclines in patients older than 70 years? Pro.
Bernardi
Daniele
D
Centro di Riferimento Oncologico, Divisione di Oncologia Medica A, Aviano (PN).
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide; D004317:Doxorubicin; D005260:Female; D006801:Humans; D008017:Life Expectancy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D011241:Prednisone; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014750:Vincristine
D000903:Antibiotics, Antineoplastic; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone